Skip to main content
UniHealth

Doctor search

Punita Grover, MD

Hematology/Oncology · Minneapolis

NPI 1184001729

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
6

Offices

6 locations · Fairview Express Care · Fairview Specialty Services

Looking this up.

Hospitals listed: Fairview Hospital University · M Health Fairview St John'S Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Grover’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A173434 · Delinquent

Licence status: Delinquent · since 2021 · expires 2023-07-31 · University of Delhi, University College of Medical Sciences and Gtb Hospital.

License renewal fee has not been paid. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • M Health Fairview St John'S HospitalMaplewood, MNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Fairview Health Services, which runs 13 hospitals in 2 statesPatients rate it 3 of 5 · 66% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.182, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.203, Oct 2024 – Sep 2025
  • M Health Fairview University of Mn Medical CenterMinneapolis, MNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Fairview Health Services, which runs 13 hospitals in 2 statesHome of Masonic Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 69% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.3 (5.7 to 9.1) · 707 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (11.6 to 16.3) · 707 cases, Jan 2024 – Dec 2024Better than the national rate — Pressure ulcer rate: 0.16 (0 to 0.61) · 6,733 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.425, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.56, Oct 2024 – Sep 2025
See every measure and the patient survey for M Health Fairview St John'S Hospital

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 2 better, 8 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at M Health Fairview St John'S Hospital
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.182BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.203BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.84 (0 to 1.82) · 897 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.58 to 1.21)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.24 (137.97 to 238.51) · 66 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.1 · 88 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.4 · 57 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.4 · 124 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.3 · 401 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12 · 313 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 307 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 3,713 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,186 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 4,320 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.58 (2.46 to 6.7) · 1,113 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.92 (0.44 to 3.41) · 417 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.35 (0.72 to 3.98) · 479 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.31 (0.35 to 12.27) · 433 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.36 (1.83 to 8.89) · 399 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.63 (0.15 to 3.1) · 257 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.38 (0 to 1.08) · 3,573 casesNo differentJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.581No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.27No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.53No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 401 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.4 · 933 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-7.8 · 151 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-2.8 · 431 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-15.1 · 339 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.6 · 754 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits7.3 (5.3 to 10.1) · 175 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.9 (8.3 to 14.2) · 175 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits10.3 · 175 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits17.6 · 175 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.7 (10.2 to 18.5) · 87 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.6) · 211 casesNo differentJan 2024 – Dec 2024

What patients said (456 patients answered, 22% of those asked)

Patient survey stars by topic at M Health Fairview St John'S Hospital
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at M Health Fairview St John'S Hospital
Room was "always" clean64%
Nurses "always" communicated well75%
Doctors "always" communicated well76%
Staff "always" explained54%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand70%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital66%
Staff "always" explained possible side effects42%
Yes, staff "did" give patients information about possible symptoms85%
See every measure and the patient survey for M Health Fairview University of Mn Medical Center

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at M Health Fairview University of Mn Medical Center
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits7.3 (5.7 to 9.1) · 707 casesWorseJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.9 (11.6 to 16.3) · 707 casesWorseJan 2024 – Dec 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.61) · 6,733 casesBetterJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0.425BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.56BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.57) · 2,072 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.85 (0.64 to 1.06)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths198.81 (161.42 to 236.2) · 247 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 66 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.1 · 27 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.9 · 44 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 190 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.1 · 181 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10 · 177 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.5 · 2,958 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.14 (0 to 0.34) · 6,968 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.32 (0.14 to 0.51) · 7,891 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.8 (3.15 to 6.45) · 2,510 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.01 (0.8 to 3.22) · 1,474 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.72 (0.41 to 3.03) · 1,587 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.36 (4.84 to 11.88) · 1,468 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.34 (2.11 to 6.57) · 1,546 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.6 (0.27 to 2.94) · 820 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths6.3 · 87 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.659No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.942No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.923No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.94No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.3 · 101 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 420 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-32.5 · 62 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-7.6 · 240 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits63.6 · 179 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.9 · 397 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.8 · 98 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.8 · 62 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.5 · 93 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14 (10.6 to 18.8) · 321 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.9 to 1.4) · 322 casesNo differentJan 2024 – Dec 2024

What patients said (405 patients answered, 20% of those asked)

Patient survey stars by topic at M Health Fairview University of Mn Medical Center
Cleanliness3
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at M Health Fairview University of Mn Medical Center
Room was "always" clean63%
Nurses "always" communicated well75%
Doctors "always" communicated well78%
Staff "always" explained56%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge91%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully77%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)68%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital69%
Staff "always" explained possible side effects42%
Yes, staff "did" give patients information about possible symptoms88%

Original Medicare doctor bills

$18,458

Medicare paid this office $18,458 for 50 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes15$5,887$89
Long return visit (40+ min)28$4,917$105
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th14$2,223$23
Return visit (30+ min)13$1,614$70
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or21$1,246$24

Who their Medicare patients are

50 Original Medicare patients in 2024. Average age 67 · Women 50% · Health risk score 3.14. Sicker patients than 9 in 10 peers; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 72% · Chronic kidney disease 34% · Depression 28% · Coronary heart disease 26% · Cancer 22%.

The office billed $108,205, Medicare allowed $23,491 and paid $18,458; for 317 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202450317673.14$108,205$18,458
202322139682.05$45,035$10,153

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$6,445$91

Drugs they prescribed that Part D paid

$978,078

Pharmacies billed $978,078 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 438) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.

376 generic and 62 brand-name prescriptions · $978,078 in drug cost · 63 antibiotic prescriptions to 27 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Rezurock19$680,142$35,797
Posaconazole13$15,075$1,160
Eliquis11$6,923$629
Acyclovir81$1,588$20
Fluconazole14$751$54
See all 11 drugs
Every Part D drug this clinician prescribed
Rezurock19$680,142$35,797
Posaconazole13$15,075$1,160
Eliquis11$6,923$629
Acyclovir81$1,588$20
Fluconazole14$751$54
Valacyclovir12$556$46
Sulfamethoxazole-Trimethoprim35$420$12
Levofloxacin18$303$17
Pantoprazole19$121$6
Rosuvastatin14$54$4
Prednisone15$33$2

Year by year

Part D prescribing by year
2024438600% (0)14%$978,078
20202514NoneNone$912
20197325NoneNone$2,968
201832841NoneNone$21,468
2017466775% (22)None$38,221
2016427804% (19)None$31,497
20153512NoneNone$6,145

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2019: 1 drug

Part D drugs prescribed in 2019
Tamsulosin11$77$7

2018: 10 drugs

Part D drugs prescribed in 2018
Lantus12$3,270$272
Ventolin Hfa12$661$55
Gabapentin18$568$32
Atorvastatin18$390$22
Omeprazole19$204$11
Tamsulosin14$170$12
Metformin18$135$8
Lisinopril16$119$7
Amlodipine Besylate25$102$4
Carvedilol12$90$7

2017: 13 drugs

Part D drugs prescribed in 2017
Spiriva14$10,432$745
Ventolin Hfa14$960$69
Omeprazole17$297$17
Oxycodone-Acetaminophen12$278$23
Atorvastatin17$179$11
Gabapentin11$159$14
Pantoprazole15$158$11
Lisinopril18$105$6
Levetiracetam11$104$9
Hydrochlorothiazide14$102$7
Carvedilol24$90$4
Amlodipine Besylate18$73$4
Prednisone14$35$2

2016: 9 drugs

Part D drugs prescribed in 2016
Symbicort18$7,357$409
Gabapentin15$216$14
Potassium Chloride13$194$15
Atorvastatin14$128$9
Carvedilol25$127$5
Amlodipine Besylate24$118$5
Furosemide22$76$3
Lisinopril14$72$5
Losartan13$48$4

Money from drug and device companies

$127 in 2021

Industry payments by year
202122None$127
202033None$261
201911None$121

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.Opdivo$111
1 payment
  • Meals for Opdivo · 2021-05-04 · $111
Janssen BiotechDarzalex$16
1 payment
  • Meals for Darzalex · 2021-12-20 · $16
See all 2 published payments
Every published payment
Janssen BiotechMeals · 2021-12-20Darzalex$16
E.R. Squibb & Sons L.L.C.Meals · 2021-05-04Opdivo$111
See earlier years (2020, 2019)

2020: $261

Payments by company in 2020
CelgeneRevlimid$112
1 payment
  • Meals for Revlimid · 2020-02-04 · $112
SeagenNone$99
1 payment
  • Education · 2020-04-08 · $99
Pharmacyclics LLC An AbbVieImbruvica$50
1 payment
  • Meals for Imbruvica · 2020-03-07 · $50

2019: $121

Payments by company in 2019
CelgeneRevlimid$121
1 payment
  • Meals for Revlimid · 2019-04-01 · $121

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Incyte Corporation · Ruxolitinib, Human Chorionic Gonadotropin (Uhcg/Egf), and Dose De-Escalated Corticosteroids for Treatment of Minnesota High-Risk Acute Gvhd (Agvhd), A Phase I/II Study · 2024Their institution$96,887
Incyte Corporation · Ruxolitinib, Human Chorionic Gonadotropin (Uhcg/Egf), and Dose De-Escalated Corticosteroids for Treatment of Minnesota High-Risk Acute Gvhd (Agvhd), A Phase I/II Study · 2025Their institution$81,593

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
81.7 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1184001729
Licence
CA A173434, MO 2015014310, OH 35.134109California A173434: Delinquent · expires 2023-07-31
Group
Fairview Express Care · Fairview Specialty Services
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X); Student in a training program (390200000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2015-05-04
NPI last updated
2021-07-29
NPI record certified
2021-07-04

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 234 Goodman St, Cincinnati, OH, 45219 · 2301 Holmes St., Kansas City, MO, 64108